CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Archives of Neurology

• Publication date

  1985-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.1985.04060050091016PMID 2581531
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Decreased level of β-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type

  1983cited by this paper
• Monoamine metabolism in senile dementia of Alzheimer type.

  1983cited by this paper
• Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.

  1983cited by this paper
• Decreased level of beta-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type.

  1983cited by this paper
• Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia

  1982cited by this paper
• Reduced lumbar CSF somatostatin levels in Alzheimer's disease.

  1982cited by this paper
• Decreased CSF concentrations of homovanillic acid and gamma-aminobutyric acid in Alzheimer's disease. Age- or disease-related modifications?

  1982cited by this paper
• Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

  1982cited by this paper
• Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's type.

  1982cited by this paper
• Dopamine deficiency in the cerebral cortex in Parkinson disease

  1982cited by this paper
• Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core.

  1981cited by this paper
• Acetylcholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type

  1981cited by this paper
• Homovanillic acid and 5‐hydroxyindoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type

  1981cited by this paper
• Cell loss in the locus coeruleus in senile dementia of Alzheimer type.

  1981cited by this paper
• Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading

  1981cited by this paper
• Cerebrospinal Fluid Amine Metabolites and the Probenecid Test

  1980cited by this paper
• Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia

  1980cited by this paper
• Rapid high-performance liquid chromatographic method for the determination of probenecid in biological fluids.

  1980cited by this paper
• Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

  1980cited by this paper
• Biogenic amines in human brain in normal aging, senile dementia, and chronic alcoholism.

  1980cited by this paper
• Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type

  1979cited by this paper
• A simple, sensitive method for measuring 3,4-dihydroxyphenylacetic acid and homovanillic acid in rat brain tissue using high-performance liquid chromatography with electrochemical detection.

  1979cited by this paper
• CSF studies on the relationship between dopamine and 5-hydroxytryptamine in Parkinsonism and other movement disorders.

  1977cited by this paper
• Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.

  1977cited by this paper
• Neuronal loss, neurofibrillary tangles and granulovacuolar degeneration in the hippocampus with ageing and dementia

  1977cited by this paper
• The effect of probenecid on the free and conjugaed 3-methoxy-4-hydroxyphenylglycol (MHPG) in lumbar cerebrospinal fluid.

  1976cited by this paper
• Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.

  1976cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Clearance of 3‐methoxy‐4‐hydroxyphenylglycol from the cerebrospinal fluid

  1976cited by this paper
• Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.

  1974cited by this paper
• ACID MONOAMINE METABOLITES IN CEREBROSPINAL FLUID FROM PATIENTS WITH PRESENILE DEMENTIA (ALZHEIMER'S DISEASE)

  1973cited by this paper
• Effect of probenecid on free 3-methoxy-4-hydroxyphenylethylene glycol (MHPG) and its sulphate in human cerebrospinal fluid.

  1973cited by this paper
• Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.

  1973cited by this paper
• Effect of intravenously administered probenecid in humans on the levels of 5-hydroxyindoleacetic acid, homovanillic acid and 3-methoxy-4-hydroxy-phenylglycol in cerebrospinal fluid.

  1971cited by this paper
• Cerebral metabolites in cerebrospinal fluid as a biochemical approach to the brain.

  1970cited by this paper
• The Investigation of Homovanillic Acid in the Human Brain and its Correlation to Senile Dementia

  1969cited by this paper
• HOMOVANILLIC ACID AND 5‐HYDROXYINDOLEACETIC ACID IN THE CEREBROSPINAL FLUID OF PATIENTS WITH SENILE DEMENTIA, PRESENILE DEMENTIA AND PARKINSONISM

  1969cited by this paper
• Concentrations of 5-Hydroxyindole-acetic Acid and Homovanillic Acid in the Cerebrospinal Fluid after Treatment with Probenecid in Patients with Parkinson's Disease

  1968cited by this paper
• Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.

  1968cited by this paper
• Parkinsonism

  1967cited by this paper

• LC-MS/MS analysis of twelve neurotransmitters and amino acids in mouse cerebrospinal fluid.

  2020cites this paper
• Homovanillic acid in CSF of mild stage Parkinson's disease patients correlates with motor impairment

  2017cites this paper
• Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review.

  2015cites this paper
• Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease

  2014cites this paper
• Is elevated norepinephrine an etiological factor in some cases of Parkinson's disease?

  2014cites this paper
• Neurochemical biomarkers in the differential diagnosis of movement disorders

  2009cites this paper
• Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease

  2009cites this paper
• The pallidoreticular pattern of brain damage on MRI in a patient with carbon monoxide poisoning

  1998cites this paper
• The basis for behavioural disturbances in dementia.

  1996cites this paper
• Early Detection of Parkinson’s Disease

  1996cites this paper
• Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion.

  1995cites this paper
• Neurobiologic Bases of Noncognitive Behavioral Problems in Alzheimer Disease

  1994cites this paper
• Monoamines and their metabolites in plasma and lumbar cerebrospinal fluid of Chinese patients with Parkinson's disease.

  1993cites this paper
• Biogenic amine metabolites in the CSF of patients with late onset and alcoholic ataxias

  1993cites this paper
• Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors.

  1992cites this paper
• Significance of decreased lumbar CSF levels of HVA and 5-HIAA in Alzheimer's disease.

  1992cites this paper
• Total plasma 3‐methoxy‐4‐hydroxyphenylglycol (MHPG) in alzheimer patients. Comparison with depressives and normal controls

  1990cites this paper
• HPLC-ECD法による生体アミン,及び代謝産物の同時測定と臨床応用:パーキンソン病と老年痴呆を中心に

  1990cites this paper
• Neurodegenerative diseases: CSF amines, lactate and clinical findings

  1990cites this paper
• Dominantly inherited apathy, central hypoventilation, and Parkinson's syndrome

  1990cites this paper
• Early Stages of Late Onset Alzheimer's Disease

  1989cites this paper
• Catecholamines in urine, blood and cerebrospinal fluid

  1989cites this paper
• Early Stages of Late Onset Alzheimer's Disease

  1989cites this paper
• Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects.

  1989cites this paper
• Neuropeptides, amines and amine receptors in the human spinal cord: the effects of Parkinson's disease

  1989cites this paper
• Biogenic amines and their metabolites in neurodegenerative diseases

  1989cites this paper
• Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features

  1988cites this paper
• Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.

  1988cites this paper
• High-performance liquid chromatographic method for measuring homovanillic acid in cerebrospinal fluid using electrochemical detection with internal standardization.

  1988cites this paper
• Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.

  1987cites this paper
• Correlation of autonomic dysfunction to CSF concentrations of noradrenaline and 3-methoxy-4-hydroxyphenylglycol in Parkinson's disease.

  1987cites this paper
• Correlation of the severity of autonomic dysfunction to cardiovascular reflexes and to plasma noradrenaline levels in Parkinson's disease.

  1987cites this paper
• Serotonin Neurones and Receptors in Alzheimer’s Disease

  1986cites this paper
• Piracetam combined with lecithin in the treatment of Alzheimer's disease.

  1986cites this paper
• Antemortem markers of Alzheimer's disease.

  1986cites this paper
• Diagnostic Methods in Alzheimer’s Disease: Magnetic Resonance Brain Imaging and CSF Neurotransmitter Markers

  1986cites this paper
• CSF neurotransmitter markers in Alzheimer's disease.

  1986cites this paper
• Antemortem laboratory diagnosis of Alzheimer's disease

  1986cites this paper
• TO THE EDITOR A single focus of multiple sclerosis in the cervical spinal cord mimicking a radiculopathy

  year unknowncites this paper